《外圍股市》美股期貨全面反覆靠穩
亞太區股市今天個別發展,滬指及深成收市分別回升0.7%及續升1.3%;印尼、日經及澳紐股市升0.3%-0.8%;餘下均反覆受壓,尤其是菲股四連跌,今天假後重開反覆跌1.7%;港股受累於重磅新經濟股、安踏(02020.HK)及遭主要股東減持藥明生物(02269.HK)續捱沽及中資金融股普遍受壓三連跌,今天反覆續跌0.3%曾失守二萬七關。
美股繼昨晚在趁低盤吸納下全面反彈逾1.5%後,期貨全面反覆靠穩,道指期貨高低見34,508/34,361,現造34,410,續升10點;標普五百期貨高低見4,327/4,310,現造4,317,反覆續升1點;昨天結束五連跌反彈的納指一百期貨高低見14,751/14,687,現造14,724,續升1點。
Follow us
Find us on
Facebook,
Twitter ,
Instagram, and
YouTube or frequent updates on all things investing.Have a financial topic you would like to discuss? Head over to the
uSMART Community to share your thoughts and insights about the market! Click the picture below to download and explore uSMART app!

Disclaimers
uSmart Securities Limited (“uSmart”) is based on its internal research and public third party information in preparation of this article. Although uSmart uses its best endeavours to ensure the content of this article is accurate, uSmart does not guarantee the accuracy, timeliness or completeness of the information of this article and is not responsible for any views/opinions/comments in this article. Opinions, forecasts and estimations reflect uSmart’s assessment as of the date of this article and are subject to change. uSmart has no obligation to notify you or anyone of any such changes. You must make independent analysis and judgment on any matters involved in this article. uSmart and any directors, officers, employees or agents of uSmart will not be liable for any loss or damage suffered by any person in reliance on any representation or omission in the content of this article. The content of the article is for reference only and does not constitute any offer, solicitation, recommendation, opinion or guarantee of any securities, virtual assets, financial products or instruments. Regulatory authorities may restrict the trading of virtual asset-related ETFs to only investors who meet specified requirements. Any calculations or images in the article are for illustrative purposes only.
Investment involves risks and the value and income from securities may rise or fall. Past performance is not indicative of future performance. Please carefully consider your personal risk tolerance, and consult independent professional advice if necessary.